<DOC>
	<DOCNO>NCT00664391</DOCNO>
	<brief_summary>The purpose study demonstrate safety gynecological formulation normal usual usage condition Dermacyd Breeze .</brief_summary>
	<brief_title>Safety Dermatological Evaluation : Acceptability With Gynecological Follow - Dermacyd Breeze</brief_title>
	<detailed_description />
	<mesh_term>Dermatologic Agents</mesh_term>
	<criteria>Integral skin test region ; Lactation gestational risk gestation ; Use Antiinflammatory immunosuppression drug 1 month study ; Topical medication use region treat ; Cutaneous disease active gynecological disease may interfere study result ; Personal history allergic disease area treat ; Allergic atopic history ; The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>